The risk of kidney disease following a Covid-19 infection is significantly higher than that associated with influenza, according to a new study published in February 2026. Researchers found that Covid-19 is linked to a substantially increased risk of both acute and chronic kidney disease, raising concerns about the long-term health consequences of the pandemic and highlighting the need for increased monitoring of kidney health in those who have been infected. This finding underscores the importance of understanding the lasting impact of viral infections on organ systems beyond the respiratory tract.
The study, published in Nature, analyzed data from nearly 4 million Americans between January 2020 and December 2021. Researchers at the Penn State College of Medicine, led by Yue Zhang, utilized the MarketScan database to compare outcomes in three groups: individuals diagnosed with Covid-19 (939,241 patients), those with influenza but not Covid-19 (199,071 patients), and a control group with neither infection (1,878,482 individuals). The research focused on the incidence of acute kidney injury (AKI), chronic kidney disease (CKD), end-stage renal disease (ESRD), and glomerular diseases.
Covid-19’s Impact on Kidney Health: A Clear Disparity
The findings revealed a stark difference in kidney-related outcomes between the Covid-19 and influenza groups. Individuals who contracted Covid-19 experienced a significantly higher incidence of AKI (8.93 cases per 100,000 person-years), CKD (6.36 cases per 100,000 person-years), and ESRD (0.64 cases per 100,000 person-years) compared to those with influenza and the control group. Specifically, Covid-19 patients showed a 2.74 times higher risk of AKI, a 1.38 times higher risk of CKD, and a 3.22 times higher risk of ESRD compared to influenza patients. Notably, influenza did not demonstrate a significant increase in risk for CKD or ESRD.
The study also examined the timeline of these risks. Researchers followed a subset of the cohort for up to 540 days and found that even as both Covid-19 and influenza initially increased the risk of AKI, the impact of Covid-19 was more pronounced in the short term—within the first 180 days—with a hazard ratio of 4.35 compared to 1.51 for influenza. The increased risk of CKD associated with Covid-19 remained consistent throughout the 540-day follow-up period, with a hazard ratio of 1.4.
Long-Term Implications and Monitoring Needs
These findings have significant implications for post-Covid-19 care. The heightened risk of AKI suggests a critical need for increased monitoring of kidney function in individuals following a Covid-19 infection, particularly in the immediate aftermath of the illness. Long-term surveillance for CKD is also warranted, as the study indicates a sustained increased risk even months after the initial infection.
The study’s authors emphasize that the increased risk of kidney disease observed after Covid-19 infection could contribute to the growing burden of kidney disease in the United States. Epidemiologists at GlobalData currently forecast over 2.2 million diagnosed incident cases of AKI, 5.3 million diagnosed prevalent cases of CKD, and over 750,000 diagnosed prevalent cases of ESRD in the U.S. In 2026. While determining the exact proportion of these cases attributable to Covid-19 remains a challenge, the study suggests that the virus should be considered a potential risk factor.
Understanding Acute vs. Chronic Kidney Disease
It’s important to understand the difference between AKI and CKD. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) defines AKI as a sudden decrease in kidney function, while CKD is a gradual loss of kidney function over time. Both conditions can lead to ESRD, requiring dialysis or a kidney transplant.
The researchers acknowledge that further investigation is needed to fully understand the mechanisms by which Covid-19 impacts kidney health. Potential factors include direct viral infection of kidney cells, inflammation, and the formation of blood clots. However, the current findings provide compelling evidence of a link between Covid-19 and an increased risk of kidney disease, emphasizing the importance of proactive monitoring and preventative measures.
As the long-term effects of Covid-19 continue to unfold, ongoing research will be crucial to refine our understanding of the virus’s impact on various organ systems and to develop effective strategies for mitigating its lasting consequences. The next phase of research will likely focus on identifying individuals at highest risk and developing targeted interventions to prevent the progression of kidney disease in post-Covid-19 patients.
Have thoughts on this story? Share your comments below, and consider sharing this article with your network to raise awareness about the potential long-term health impacts of Covid-19.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
